Companies/US/ENGN

ENGENE THERAPEUTICS INC.

Last · NASDAQ$1.82-0.01 (-0.55%)stale · yahoo · 92h ago
Market cap$121.92M67.0M sh
P/E · TTM-0.8fwd -1.3 · eps -2.18 · loss
Beta-0.27vs S&P 500
Div yieldannual · TTM
52w range
$1.40$12.25
Volume412.7Ksession

Issuer

Legal nameENGENE THERAPEUTICS INC.
HQUnited States (US)
ListingUS ENGN
ISINCA29286X1015
SectorHealthcare
IndustryDrugs (Biotechnology)
SIC2836
CurrencyUSD
Entity registrysec:0001980845
CIK0001980845
LinkedIn
Employees82
AddressenGene Holdings, Inc. 4868 Rue Levy H4R 2P1, Saint-Laurent
Loading chart…

OpenFilings analyst

Our analyst

10-K · 2025-12-22

From latest 10-K · 2025-12-22

  • Operating Cf Burn
  • Cash Runway Low
  • Accumulated Deficit High

Red flags

  • Operating Cf Burn — Negative operating cash flow
  • Cash Runway Low — Cash runway ~0.5 years
  • Accumulated Deficit High — Accumulated deficit / equity 222%

Earnings

2 events
Reported · 1:30 PM UTC+2
Period
Jun 2026
EPS
−$0.47Missed−9.3%
Est. revenue
2:30 PM UTC+2
Period
Jul 2026
Est. EPS
−$0.43
Est. revenue
0

Documents

FormReporting forFiledFlags
2026-09-082026-09-080
2026-07-312026-09-08 3
2026-08-112026-08-110
2026-07-172026-07-170
2026-07-152026-07-160